Screening for Lung Cancer.
Lung cancer is a global health burden and is among the most common and deadliest of all malignancies worldwide. The goal of screening programs is to detect tumors in earlier, curable stages, consequently reducing disease-specific mortality. The issue of screening has great relevance to thoracic surgeons, who should play a leading role in the debate over screening and its consequences. The burden is on thoracic surgeons to work in a multidisciplinary setting to guide and treat these patients safely and responsibly, ensuring low morbidity and mortality of potential diagnostic or therapeutic interventions.
Division of Thoracic Surgery, New York-Presbyterian Hospital, Weill Cornell Medicine, 525 East 68th Street, New York, NY 10065, USA.
Brendon M
BM
Stiles
Department of Radiology, New York-Presbyterian Hospital, Weill Cornell Medicine, 525 East 68th Street, New York, NY 10065, USA.
Bradley
B
Pua
Division of Thoracic Surgery, New York-Presbyterian Hospital, Weill Cornell Medicine, 525 East 68th Street, New York, NY 10065, USA. Electronic address: nkaltork@med.cornell.edu.
Nasser K
NK
Altorki
D055088:Early Detection of Cancer / Q000379:methods*; D014943:Global Health; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000517:prevention & control*; D008403:Mass Screening; D010818:Practice Patterns, Physicians'; D024382:Professional Role; D066231:Surgeons
Lung cancer; Pulmonary nodules; Screening; Thoracic surgeons